Nano Science and Technology InstituteNano Science and Technology Institute
Nano Science and Technology Institute 2004 NSTI Nanotechnology Conference & Trade Show
Nanotech 2004
BioNano 2004
Business & Investment
2004 Sub Sections
Venue 2004
Press Room
Nanotech Conference History
Nanotech Organizers
Press Releases
News Clips
NSTI Outreach
Media Attendance
Purchase CD/Proceedings
NSTI Events
Site Map
Nanotech Proceedings
Nanotechnology Proceedings
Supporting Organizations
Nanotech Supporting Organizations
Media Sponsors
Nanotech Media Sponsors
Event Contact
696 San Ramon Valley Blvd., Ste. 423
Danville, CA 94526
Ph: (925) 353-5004
Fx: (925) 886-8461
  March 05, 2004 04:06 PM US Eastern Timezone

Biophan Technologies to Present at Nanotech 2004 Conference; Biophan present at the Nanotech Early Stage Industry Review at 7:00 p.m. on Monday March 8, 2004

NanoTech 2004

ROCHESTER, N.Y.--(BUSINESS WIRE)--March 5, 2004--Biophan Technologies, Inc. (OTCBB: BIPH) an innovator, developer and marketer of MRI-related and other advanced biomedical technology, announced today that it will present at the Nanotech 2004 Conference being held March 7-9, 2004, at the Boston Sheraton Hotel in Boston, MA. Michael Weiner, Biophan's CEO, will present at the Nanotech Early Stage Industry Review at 7:00 p.m. on Monday, March 8, 2004.

Biophan's technologies include filtering, shielding, coating, imaging, and photonic solutions to both MRI safety and MRI image compatibility. NanoView(TM), Biophan's newest technology, will utilize nanomagnetic particles as contrast agents that preferentially bind to tissues of diagnostic interest, creating improved detail and contrast in images. Mr. Weiner will give an overview of this recently acquired technology and other nanotechnology capabilities that may influence the biomedical device industry in the near future. (

About Biophan Technologies

Biophan Technologies develops and markets cutting-edge technologies used to make biomedical devices--such as cardiac pacemakers, surgical and diagnostic tools--safe and compatible with magnetic resonance imaging (MRI) equipment. The technology is also being used to create enhanced MRI contrast agents. Committed to growth through innovation and developmental leadership, Biophan and its licensors have four issued U.S. patents and over fifty patents pending, in areas including nanomagnetic particle coatings, radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit

About This Conference

For more information on this conference, please visit

Safe Harbor Statement:

Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of the Company's MRI technologies; the approval of the Company's patent applications; the successful implementation of the Company's research and development programs; the acceptance by the market of the Company's products; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.


Biophan Technologies, Inc.
Carolyn Hotchkiss, 585-214-2407
Press Interviews:
Michael Weiner, 585-214-2441

Nanotech Sponsors
News Headlines
NSTI Online Community

© Nano Science and Technology Institute, all rights reserved.
Terms of use | Privacy policy | Contact